EMERYVILLE, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. ZGNX, a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will participate in a fireside chat at the Stifel 2016 Healthcare Conference.
Stifel 2016 Healthcare Conference
| Date: | Tuesday, November 15, 2016 | |
| Time: | 3:45 pm Eastern Time / 12:45 pm Pacific Time | |
| Location: | New York, NY |
The presentation will be webcast live and can be accessed on Zogenix's Investor Relations website at ir.zogenix.com.
About Zogenix
Zogenix, Inc. ZGNX is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
For more information, visit www.zogenix.com.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
